Lunit Revamps Board by Recruiting Global Healthcare Experts

[Asia Economy Reporter Chunhee Lee] Medical artificial intelligence (AI) company Lunit is accelerating its global management by reorganizing its board of directors with overseas and governance experts.

On the 30th, Lunit held a general shareholders' meeting and appointed Galheng Kong, managing partner who founded the global healthcare investment venture capital HealthQuest Capital, as an outside non-executive director.

Managing Partner Galheng graduated from Stanford University and Duke University School of Medicine in the U.S. After working at global pharmaceutical company GlaxoSmithKline (GSK) and healthcare-focused venture investment firms, he established HealthQuest in 2012. As a physician-scientist (MD-PhD) and a globally renowned investment expert in the healthcare field, he is expected to actively participate in strategic decision-making to help Lunit enter the global market more quickly and effectively.

Starting from this general meeting, the number of inside directors was reduced from four to two, consisting of Chairman Baek Seung-wook and CEO Seo Beom-seok, and the entire board was reorganized into four members, including Galheng as an outside non-executive director and Nam-i Jeong, appointed as an outside director last September and currently executive director of the Asan Nanum Foundation. Lunit added, "We plan to recruit additional external directors to ensure management transparency and to form a board that meets global standards."

Additionally, Lunit plans to actively promote the board observer system to strengthen the independence and efficiency of governance. The board observer system allows participation in the board and the ability to provide opinions but does not grant the rights and duties such as voting rights held by directors. Lunit intends to appoint Helmi Elttuki, co-CEO of global biohealth company Guardant Health, and Boseon How, managing director of venture investment firm Tybourne Asset Management, as observers to enhance governance transparency.

Through the general meeting, Lunit also established a compensation committee and an outside director nomination committee, with plans to decide the chairpersons at a future board meeting.

Baek Seung-wook, chairman of Lunit’s board, said, "It is extremely rare for a domestic healthcare company to appoint distinguished overseas experts as outside non-executive directors or other board members in the global healthcare market. Through this, Lunit’s global expertise is further strengthened, and we will accelerate our full-scale global market expansion."

This content was produced with the assistance of AI translation services.